HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Isabelle Soubeyran Selected Research

Neoplasms (Cancer)

4/2024Human NLRC4 promotes cancer survival and is associated to type-I interferon signaling and immune infiltration.
4/2024Are DNA Repair Gene Alterations Associated With the Response to Platinum-Based Regimen and Immune Checkpoint Inhibitors in Patients With Solid Tumors?
11/2023Pan-TRK immunohistochemistry in gynaecological mesenchymal tumours: diagnostic implications and pitfalls.
11/2023Circulating tumor DNA landscape and prognostic impact of acquired resistance to targeted therapies in cancer patients: a national center for precision medicine (PRISM) study.
10/2023The KAT6B::KANSL1 Fusion Defines a New Uterine Sarcoma With Hybrid Endometrial Stromal Tumor and Smooth Muscle Tumor Features.
1/2023Standardized Pathology Screening of Mature Tertiary Lymphoid Structures in Cancers.
1/2023Multicenter Harmonization Study of Pan-Trk Immunohistochemistry for the Detection of NTRK3 Fusions.
10/2022Genomics to select treatment for patients with metastatic breast cancer.
1/2022Spatial transcriptomics of macrophage infiltration in non-small cell lung cancer reveals determinants of sensitivity and resistance to anti-PD1/PD-L1 antibodies.
1/2022Comprehensive Genome Profiling in Patients With Metastatic Non-Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 Trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Isabelle Soubeyran Research Topics

Disease

42Neoplasms (Cancer)
04/2024 - 12/2007
12Colorectal Neoplasms (Colorectal Cancer)
04/2024 - 03/2004
7Neoplasm Metastasis (Metastasis)
11/2022 - 07/2010
5Sarcoma (Soft Tissue Sarcoma)
10/2020 - 03/2011
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2023 - 03/2016
3Adenocarcinoma
05/2023 - 01/2013
3Carcinoma (Carcinomatosis)
01/2021 - 02/2014
3Colonic Neoplasms (Colon Cancer)
10/2019 - 06/2007
3Breast Neoplasms (Breast Cancer)
01/2015 - 07/2010
3Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2007 - 11/2005
2Disease Progression
11/2023 - 11/2020
2Tertiary Lymphoid Structures
01/2023 - 01/2021
2Anaplastic Thyroid Carcinoma
01/2020 - 07/2015
2Aggressive Fibromatosis (Desmoid)
12/2012 - 04/2012
1Leiomyoma (Uterine Fibroids)
03/2024
1Leiomyosarcoma
02/2024
1Bites and Stings (Sting)
11/2023
1Stomach Neoplasms (Stomach Cancer)
05/2023
1COVID-19
01/2023
1Spontaneous Remission
11/2022
1Endometrial Neoplasms (Endometrial Cancer)
04/2022
1Lymphatic Metastasis
04/2022
1Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2022
1Virus Diseases (Viral Diseases)
01/2021
1Prostatic Neoplasms (Prostate Cancer)
01/2021
1Mesenchymal Chondrosarcoma
10/2020
1Kidney Neoplasms (Kidney Cancer)
01/2020
1Renal Cell Carcinoma (Grawitz Tumor)
01/2020
1Carcinogenesis
01/2019

Drug/Important Bio-Agent (IBA)

6RNA (Ribonucleic Acid)IBA
10/2023 - 03/2011
6Biomarkers (Surrogate Marker)IBA
01/2023 - 03/2016
6Proteins (Proteins, Gene)FDA Link
01/2021 - 05/2011
5Immune Checkpoint InhibitorsIBA
04/2024 - 01/2021
5DNA (Deoxyribonucleic Acid)IBA
10/2023 - 12/2007
5AntibodiesIBA
01/2023 - 05/2010
5Formaldehyde (Formol)FDA Link
01/2021 - 03/2011
5ParaffinIBA
01/2021 - 12/2007
3Anaplastic Lymphoma KinaseIBA
01/2020 - 01/2014
3Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2013 - 12/2007
2InflammasomesIBA
04/2024 - 11/2020
2PlatinumIBA
04/2024 - 01/2021
2Hormones (Hormone)IBA
11/2023 - 07/2010
2Estrogens (Estrogen)FDA Link
10/2023 - 01/2019
2avelumabIBA
01/2022 - 01/2021
2regorafenibIBA
01/2022 - 01/2021
2Keratins (Keratin)IBA
11/2021 - 10/2020
2olaparibIBA
01/2021 - 01/2021
2Aggrecans (Aggrecan)IBA
10/2020 - 10/2020
2CrizotinibIBA
01/2020 - 07/2015
2FurinIBA
01/2020 - 10/2019
2EnzymesIBA
10/2019 - 01/2015
2CateninsIBA
01/2019 - 12/2012
2ThyroglobulinFDA Link
09/2014 - 01/2013
2Irinotecan (Camptosar)FDA LinkGeneric
06/2007 - 03/2004
1Interleukin-12 (IL 12)IBA
04/2024
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2024
1ChemokinesIBA
04/2024
1Interferon Type IIBA
04/2024
1Fumarate Hydratase (Fumarase)IBA
03/2024
1Calmodulin-Binding Proteins (Caldesmon)IBA
02/2024
1Monoclonal AntibodiesIBA
11/2023
1Tyrosine Kinase InhibitorsIBA
11/2023
1Circulating Tumor DNAIBA
11/2023
1Progesterone Receptors (Progesterone Receptor)IBA
10/2023
1CollagenIBA
10/2023
1Complementary DNA (cDNA)IBA
10/2023
1ClaudinsIBA
05/2023
1VaccinesIBA
01/2023
1Immunoglobulin G (IgG)IBA
01/2023
1Eosine Yellowish-(YS) (Eosin)IBA
01/2023
1Hematoxylin (Haematoxylon)IBA
01/2023
1InterferonsIBA
01/2022
1B7-H1 AntigenIBA
01/2022
1durvalumabIBA
01/2022
1DesminIBA
11/2021
1Bevacizumab (Avastin)FDA Link
01/2021
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2021
1AMP-Activated Protein KinasesIBA
01/2021
1taxaneIBA
01/2021
1Interleukin-18 (Interleukin 18)IBA
11/2020
1Mechanistic Target of Rapamycin Complex 1IBA
01/2020
1ApelinIBA
01/2020
1ceritinibIBA
01/2020
1brigatinibIBA
01/2020
1Sunitinib (Sutent)FDA Link
01/2020
1Apelin ReceptorsIBA
01/2020
1Programmed Cell Death 1 ReceptorIBA
10/2019
1arginylvalineIBA
10/2019
1Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA
10/2019
1MyogeninIBA
01/2019
1Lapatinib (GW572016)FDA Link
01/2018

Therapy/Procedure

9Therapeutics
11/2023 - 12/2007
4Drug Therapy (Chemotherapy)
04/2024 - 01/2013
4Immunotherapy
05/2023 - 01/2015
3Precision Medicine
04/2024 - 01/2022
3Radiotherapy
03/2017 - 01/2013
2Adjuvant Chemotherapy
07/2010 - 06/2007
1Radiofrequency Ablation
11/2022
1Castration
01/2021
1Genomic Medicine
01/2020